Aquestive Therapeutics (AQST): Director received 57K units
Richard J Daly, Director at Aquestive Therapeutics, reported a grant / award of 57K units.
- 57K
- Derivative units
- Traded
- Nov 6, 2026
- Filed
- Nov 10, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 29, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 29, 2026, Aquestive Therapeutics, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has elected Richard J. Daly as a director of the Company, effective October 14, 2026.”
- Oct 7, 20265% stakeBRATTON DOUGLAS K reported a passive stake (13G) of 0.6%
- Oct 7, 20265% stakeBass Edward P reported a passive stake (13G) of 7.5%
- Oct 13, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Oct 15, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Oct 15, 2026InsiderCEO sold ~$106K of AQST shares in the open market
- Nov 3, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
What came next
- Nov 10, 2026Insider · 1 personInsiders: 2 purchases (~$99K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Aquestive Therapeutics
For Aquestive Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AQST page.
Other recent filings by Richard J Daly, Director
- SEC Form 4 at Aquestive Therapeutics (AQST)Nov 12, 2026
- SEC Form 4 at Aquestive Therapeutics (AQST)Nov 12, 2026
The full history of Richard J Daly, Director is on the profile page.
How this filing works
Explore the data
Other disclosures at Aquestive Therapeutics
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Oct 16, 2026
- SEC Schedule 13GOct 7, 2026
- SEC Schedule 13GOct 7, 2026
Everything OQRO holds on this company is on its AQST page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
